What is a Public Assessment Report (PAR)?
A Public Assessment Report (PAR) is an official regulatory document that provides a scientific summary of the evaluation of a medicinal product after it has been approved. It explains how a regulatory authority assessed the quality, safety, and efficacy of a product before granting marketing authorization. The PAR promotes transparency by making key assessment details publicly accessible.
Purpose of a Public Assessment Report (PAR)
The primary purpose of a Public Assessment Report is to communicate the scientific reasoning behind a product’s approval. It includes information on:
- Product background and therapeutic indication
- Quality (Chemistry, Manufacturing, and Controls) assessment
- Non-clinical (preclinical) evaluation
- Clinical study data and benefit-risk analysis
- Final regulatory decision and conditions of approval
Regulatory authorities such as the European Medicines Agency (EMA) publish detailed assessment reports known as the European Public Assessment Report (EPAR). Similarly, the Medicines and Healthcare products Regulatory Agency (MHRA) publishes Public Assessment Reports for medicines authorized in the United Kingdom.
Importance of Public Assessment Reports in Regulatory Affairs
Public Assessment Reports enhance regulatory transparency and build trust among healthcare professionals, patients, and stakeholders. They provide valuable insights into the evaluation process and clarify the benefit-risk balance considered during approval.
For pharmaceutical companies, PARs serve as reference documents for future submissions, lifecycle management activities, and global regulatory strategy. They also help competitors and researchers understand regulatory expectations and scientific standards.
Benefits of Public Assessment Reports (PAR)
- Promotes transparency in regulatory decision-making
- Strengthens public confidence in approved medicines
- Supports scientific knowledge sharing
- Provides guidance for regulatory and compliance professionals
In modern Regulatory Affairs, Public Assessment Reports (PARs) are essential tools that ensure openness, accountability, and evidence-based decision-making in the approval of medicinal products.